2026 Investor Deck · page 9 of 15
The slide presents clinical trial data for Ivonescimab in NSCLC, showing consistent HR improvements across different patient populations.
Consulting deck · data_table · quantify_impact · overcrowded density
Slide locked Sign in to view
Slide schematic 9/9
callout 1/1 chart 3/3 paragraph 1/1 table 3/3 title 1/1
Components 9
primary line line line paragraph data data data headline
Tools 2
Chartjunk Elimination slide · 70%
The slide's charts and tables appear to be clear and uncluttered, suggesting an effort to eliminate unnecessary visual elements.
Data-Ink Ratio slide · 70%The slide features multiple tables and charts with data, indicating a focus on data visualization and efficient use of ink to convey information.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.